Birdwatch Note
2024-10-31 02:13:50 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Lancet系列誌メタ解析ではオミクロン初期変異への2回接種半年後の入院予防有効性は52%(表2下)、3回接種直後(7-28日)は89%です(表4下 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00015-2/fulltext 小島勢二氏は様々な話をし、ある時は接種歴不明を接種者のみに振り分け高齢2回接種者の重症予防有効性を-103％とし（下3つめの表 https://agora-web.jp/archives/2056193.html またある時は、年齢を考慮せず3回接種の死亡予防有効性を22%としこれらは上記と全く違います https://agora-web.jp/archives/231226001723.html 国会で答弁された様に接種歴不明は接種が有、無、不明の項目が未入力の方も該当し 下記9P2段目 https://kokkai.ndl.go.jp/simple/dispPDF?minId=120814260X01820220607 下記官房長会見で説明されたように接種有接種日不明は接種者に分類されてます。 https://twitter.com/xjR1BqbrppuegLj/status/1531483565980291072
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1851642701051261135
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1851809777040646290
- noteId - 1851809777040646290
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1730340830466
- tweetId - 1851642701051261135
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Lancet系列誌メタ解析ではオミクロン初期変異への2回接種半年後の入院予防有効性は52%(表2下)、3回接種直後(7-28日)は89%です(表4下 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00015-2/fulltext 小島勢二氏は様々な話をし、ある時は接種歴不明を接種者のみに振り分け高齢2回接種者の重症予防有効性を-103％とし（下3つめの表 https://agora-web.jp/archives/2056193.html またある時は、年齢を考慮せず3回接種の死亡予防有効性を22%としこれらは上記と全く違います https://agora-web.jp/archives/231226001723.html 国会で答弁された様に接種歴不明は接種が有、無、不明の項目が未入力の方も該当し 下記9P2段目 https://kokkai.ndl.go.jp/simple/dispPDF?minId=120814260X01820220607 下記官房長会見で説明されたように接種有接種日不明は接種者に分類されてます。 https://twitter.com/xjR1BqbrppuegLj/status/1531483565980291072
Note Ratings
| rated at | rated by | |
| 2024-10-31 05:22:11 -0500 | Rating Details | |
| 2024-10-31 05:18:06 -0500 | Rating Details | |
| 2024-10-31 03:32:03 -0500 | Rating Details | |
| 2024-10-31 03:30:23 -0500 | Rating Details | |
| 2024-10-30 22:57:44 -0500 | Rating Details | |
| 2024-10-31 03:16:50 -0500 | Rating Details | |
| 2024-10-31 00:05:10 -0500 | Rating Details | |
| 2024-10-30 22:51:03 -0500 | Rating Details | |
| 2024-10-30 22:37:37 -0500 | Rating Details | |
| 2024-10-30 22:09:43 -0500 | Rating Details | |
| 2024-10-30 21:55:09 -0500 | Rating Details | |
| 2024-10-30 21:46:00 -0500 | Rating Details | |
| 2024-10-31 20:37:37 -0500 | Rating Details | |
| 2024-10-31 03:56:43 -0500 | Rating Details | |
| 2024-10-31 03:38:09 -0500 | Rating Details | |
| 2024-10-31 03:36:43 -0500 | Rating Details | |
| 2024-10-31 02:27:35 -0500 | Rating Details | |
| 2024-10-31 00:25:10 -0500 | Rating Details | |
| 2024-10-30 23:36:37 -0500 | Rating Details | |
| 2024-10-30 22:36:22 -0500 | Rating Details | |
| 2024-10-30 22:27:31 -0500 | Rating Details | |
| 2024-10-30 21:58:09 -0500 | Rating Details | |
| 2024-10-30 21:29:54 -0500 | Rating Details | |
| 2024-10-31 09:47:45 -0500 | Rating Details | |
| 2024-10-31 09:27:31 -0500 | Rating Details | |
| 2024-10-31 06:39:22 -0500 | Rating Details | |
| 2024-10-30 23:05:31 -0500 | Rating Details | |
| 2024-10-30 22:51:23 -0500 | Rating Details | |
| 2024-10-30 22:43:20 -0500 | Rating Details | |
| 2024-10-30 22:15:12 -0500 | Rating Details | |
| 2024-10-30 22:02:43 -0500 | Rating Details | |
| 2024-10-30 21:56:35 -0500 | Rating Details | |
| 2024-10-30 21:42:48 -0500 | Rating Details | |
| 2024-10-30 21:22:17 -0500 | Rating Details | |
| 2024-11-02 05:03:48 -0500 | Rating Details | |
| 2024-10-31 01:09:42 -0500 | Rating Details | |
| 2024-10-31 00:55:13 -0500 | Rating Details | |
| 2024-10-31 00:25:15 -0500 | Rating Details | |
| 2024-10-30 23:31:20 -0500 | Rating Details | |
| 2024-10-30 23:20:00 -0500 | Rating Details | |
| 2024-10-30 21:22:24 -0500 | Rating Details | |
| 2024-10-30 21:21:55 -0500 | Rating Details |